Conference - London, United Kingdom
This two-day forum is the “must attend” event for those senior executives looking to drive-forward their medical affairs teams departments, develop superior evidence and enhance their KOL & stakeholder engagement at all levels.
5 EVENTS IN ONE:
1.Strategic Approaches to Value- Added Medical Affairs Management
2.Best Practices in Late- Phase Research
3.Enhancing Medical Communication & KOL Engagement for Medical Affairs
4.Medical Affairs Management for Medical Devices
5.Medical Writing & Communication for Medical Affairs
2.Best Practices in Late- Phase Research
3.Enhancing Medical Communication & KOL Engagement for Medical Affairs
4.Medical Affairs Management for Medical Devices
5.Medical Writing & Communication for Medical Affairs
WHY ATTEND ?
1.Understand how medical affairs are at the forefront of new pharmaceutical industry/stakeholder communication models and how to evolve into a more science-focused, patient-centric organisation.
2.Appreciate what are the most intelligent ways to map and engage with KOLs and other prescribers, payers, patient groups, pharmacies and tomorrow’s stakeholders.
3.Benchmark with experts to find out the best practices in late-phase research, especially observational studies, patient registries and investigator-initiated studies, to generate quality evidence.
4.Discover how Investigator Initiated Research can help you to generate value for your pharmaceutical product or medical device.
5.Learn how the modern medical affairs role can add-value for medical device companies looking to enhance their product’s lifecycle.Understand how medical affairs are at the forefront of new pharmaceutical industry/stakeholder communication models and how to evolve into a more science-focused, patient-centric organisation.
2.Appreciate what are the most intelligent ways to map and engage with KOLs and other prescribers, payers, patient groups, pharmacies and tomorrow’s stakeholders.
3.Benchmark with experts to find out the best practices in late-phase research, especially observational studies, patient registries and investigator-initiated studies, to generate quality evidence.
4.Discover how Investigator Initiated Research can help you to generate value for your pharmaceutical product or medical device.
5.Learn how the modern medical affairs role can add-value for medical device companies looking to enhance their product’s lifecycle.Understand how medical affairs are at the forefront of new pharmaceutical industry/stakeholder communication models and how to evolve into a more science-focused, patient-centric organisation.
- Organization: NextLevel Pharma
Wed, Oct 21, 2015 - Thu, Oct 22, 2015
Montcalm Marble Arch Hotel
London, United Kingdom
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
